Anzeige
Mehr »
Montag, 09.03.2026 - Börsentäglich über 12.000 News
Verdoppelt - und noch nicht am Ziel? Dieser Rohstoff-Explorer profitiert vom Antimon-Boom
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESS Newswire
177 Leser
Artikel bewerten:
(0)

Centamin PLC Announces Appointment of Non-Executive Director

PERTH, AUSTRALIA / ACCESSWIRE / March 25, 2019 / Centamin plc ("Centamin" or "the Company") (LSE: CEY, TSX: CEE) is pleased to announce the appointment of Dr. Sally Eyre, B.Sc., Ph.D., DIC, as an independent Non-Executive Director, effective 10 April 2019.

Dr. Eyre is a mining finance professional with extensive experience in global resource capital markets and mining operations. As a geologist, obtaining her doctoral degree in Economic Geology from the Royal School of Mines, Imperial College, London, Dr. Eyre brings strong technical balance to the existing Board composition.

Throughout Dr. Eyre's career, she has acquired substantial capital market, finance and directorate expertise. From 2011 to 2014, Dr. Eyre was President and Chief Executive Officer of TSX Venture Exchange listed Copper North Mining. Prior to this, from 2008 to 2011, she was an executive with Endeavour Financial, which transformed into the intermediate gold mining Company, Endeavour Mining. During this period of transformation, Dr. Eyre served as the President and Chief Executive Officer of Etruscan Resources and subsequently as Senior Vice President Operations, of Endeavour Mining.

Dr. Eyre currently holds two non-executive directorships: Adventus Zinc Corporation and Japan Gold Corporation. Adventus Zinc is a TSX Venture Exchange listed company. Dr. Eyre has been a Non-Executive Director since 2017, where she is the Chair of the Corporate Governance Committee and a member of the Audit Committee and Steering Committee. Japan Gold is a TSX Venture Exchange listed company. Dr. Eyre has been a Non-Executive Director since 2016, where she is the Chair of the Corporate Governance Committee and a member of the Audit Committee.

Following Dr. Eyre's appointment, the Centamin Board will comprise of nine members: the non-executive Chair, two Executives and six independent Non-Executives. This appointment is in accordance with the UK Corporate Governance Code and the Company's ongoing commitment to achieving the highest standards of corporate governance.

Josef El-Raghy, Chairman commented:

"We are delighted to be welcoming Sally to the Company. Her excellent technical skills and experience acquired throughout her career will be a valued addition to our existing diverse and multidisciplinary Board."

There are no further details that are required to be disclosed in respect of the appointment under LR9.6.13 of the UK FCA Listing Rules.

This announcement contains additional regulated information.

For more information, please visit the website www.centamin.com or contact:

Centamin plc
Andrew Pardey, Chief Executive Officer
Alexandra Carse, Investor Relations
+44 (0) 7700 713 738
alexandra.carse@centamin.je

Buchanan Communications
Bobby Morse
Chris Judd
+ 44 (0) 20 7466 5000
centamin@buchanan.uk.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

SOURCE: Centamin PLC



View source version on accesswire.com:
https://www.accesswire.com/540067/Centamin-PLC-Announces-Appointment-of-Non-Executive-Director

© 2019 ACCESS Newswire
Favoritenwechsel - diese 5 Werte sollten Anleger im Depot haben!
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.